<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04781595</url>
  </required_header>
  <id_info>
    <org_study_id>E-26/202.905/2019</org_study_id>
    <nct_id>NCT04781595</nct_id>
  </id_info>
  <brief_title>Watermelon and Beetroot Products on Endothelial Function</brief_title>
  <official_title>Effect of Watermelon and Beetroot Products on Endothelial Function in Young and Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease is the main cause of death worldwide. Endothelial dysfunction is the&#xD;
      first step to development of cardiovascular diseases. Endothelial dysfunction occurs due to&#xD;
      reduction in nitric oxide, a molecule that plays an important role on vascular health. Due to&#xD;
      important role of nitric oxide in endothelial function, several studies have evaluated the&#xD;
      effect of its precursors, such as L-citrulline and nitrate on endothelial function&#xD;
      parameters. The present study will evaluate the effect of L-citrulline and nitrate derived by&#xD;
      watermelon and beetroot products, respectively, on endothelial function of young and older&#xD;
      participants. Furthermore, we will evaluate the plasmatic amino acids, nitrate, glucose and&#xD;
      insulin in response to ingestion of these products.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow-mediated dilation (FMD)</measure>
    <time_frame>This measure will be evaluate before the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Flow-mediated dilation (FMD)</measure>
    <time_frame>This measure will be evaluate 60 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Flow-mediated dilation (FMD)</measure>
    <time_frame>This measure will be evaluate 120 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle oxygen saturation</measure>
    <time_frame>This measure will be evaluate before the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle oxygen saturation</measure>
    <time_frame>This measure will be evaluate 30 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle oxygen saturation</measure>
    <time_frame>This measure will be evaluate 60 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle oxygen saturation</measure>
    <time_frame>This measure will be evaluate 90 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle oxygen saturation</measure>
    <time_frame>This measure will be evaluate 120 minutes after the nutritional intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasmatic amino acids</measure>
    <time_frame>This measure will be evaluate before the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic amino acids</measure>
    <time_frame>This measure will be evaluate 30 minutes after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic amino acids</measure>
    <time_frame>This measure will be evaluate 60 minutes after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic amino acids</measure>
    <time_frame>This measure will be evaluate 90 minutes after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic amino acids</measure>
    <time_frame>This measure will be evaluate 120 minutes after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic glucose</measure>
    <time_frame>This measure will be evaluate before the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic glucose</measure>
    <time_frame>This measure will be evaluate 30 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic glucose</measure>
    <time_frame>This measure will be evaluate 60 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic glucose</measure>
    <time_frame>This measure will be evaluate 90 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic glucose</measure>
    <time_frame>This measure will be evaluate 120 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic insulin</measure>
    <time_frame>This measure will be evaluate before the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic insulin</measure>
    <time_frame>This measure will be evaluate 30 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic insulin</measure>
    <time_frame>This measure will be evaluate 60 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic insulin</measure>
    <time_frame>This measure will be evaluate 90 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic insulin</measure>
    <time_frame>This measure will be evaluate 120 min after the nutritional intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Healthy Young</condition>
  <condition>Older People With Cardiovascular Disease Risk</condition>
  <arm_group>
    <arm_group_label>Watermelon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Watermelon powder containing 3 g of L-citrulline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beetroot</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beetroot powder containing 8 mmol of nitrate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Watermelon + beetroot</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Watermelon powder containing 3 g of L-citrulline and Beetroot powder containing 8 mmol of nitrate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Watermelon</intervention_name>
    <description>A single dose of watermelon powder containing 3g of L-citrulline</description>
    <arm_group_label>Watermelon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Beetroot</intervention_name>
    <description>A single dose of beetroot powder containing 8 mmol of nitrate</description>
    <arm_group_label>Beetroot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Watermelon + beetroot</intervention_name>
    <description>A single dose of watermelon and beetroot powder containing 3g of L-citrulline and 8 mmol of nitrate</description>
    <arm_group_label>Watermelon + beetroot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A single dose of maltodextrin</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for healthy young participants:&#xD;
&#xD;
          -  Age between 18-35 years;&#xD;
&#xD;
          -  Triglycerides ≤ 150 mg/dL&#xD;
&#xD;
          -  HDL-cholesterol ≥ 50 mg/dL for women and ≥ 40 mg/dL for men;&#xD;
&#xD;
          -  Waist circumference ≤ 102 cm for men and ≤ 88 cm for women).&#xD;
&#xD;
        Inclusion Criteria for older people with cardiovascular risk:&#xD;
&#xD;
          -  Age ≥ 60 years;&#xD;
&#xD;
          -  Elevated triglycerides ≥150 mg/dL;&#xD;
&#xD;
          -  Reduced HDL-cholesterol ≤ 50 mg/dL for women and ≤ 40 mg/dL for men;&#xD;
&#xD;
          -  Elevated waist circumference ≥102 cm for men and ≥ 88 cm for women).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Elevated fasting glucose (≥100 mg/dL);&#xD;
&#xD;
          -  Smoking;&#xD;
&#xD;
          -  Beetroot or watermelon allergy;&#xD;
&#xD;
          -  Unwillingness to avoid beetroot or watermelon products during the entire study;&#xD;
&#xD;
          -  Other chronic diseases (diabetes, liver disease, etc.) or acutely ill&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thiago Alvares, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thiago Alvares, PhD</last_name>
    <phone>+5521999896554</phone>
    <email>alvares@macae.ufrj.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mônica Souza, Master</last_name>
    <phone>+5522998623136</phone>
    <email>mvolinosouza@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universidade Federal do Rio de Janeiro</name>
      <address>
        <city>Macaé</city>
        <state>Rio De Janeiro</state>
        <zip>27979-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thiago Alvares, PhD</last_name>
      <phone>+5521999896554</phone>
      <email>alvares@macae.ufrj.br</email>
    </contact>
    <contact_backup>
      <last_name>Mônica Souza, Master</last_name>
      <phone>+5522998623136</phone>
      <email>mvolinosouza@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Thiago Alvares</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>endothelial function</keyword>
  <keyword>L-citrulline</keyword>
  <keyword>nitrate</keyword>
  <keyword>nitric oxide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

